{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:14:39Z","timestamp":1790835279579,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["QD202330"],"award-info":[{"award-number":["QD202330"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.atherosclerosis.2026.120640","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:25:08Z","timestamp":1768609508000},"page":"120640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Silencing CCL5 suppresses ferroptosis to alleviate calcific aortic valve disease through chemokine pathway inhibition"],"prefix":"10.1016","volume":"414","author":[{"given":"Hongjin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120640_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/eurheartj\/ehab757","article-title":"Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.200","article-title":"Vascular calcification: molecular mechanisms and therapeutic interventions","volume":"4","author":"Pan","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117143","article-title":"Beyond VICs: shedding light on the overlooked VECs in calcific aortic valve disease","volume":"178","author":"Fan","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00395-022-00935-6","article-title":"Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?","volume":"117","author":"Broeders","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib5","article-title":"Identifying hub genes of calcific aortic valve disease and revealing the immune infiltration landscape based on multiple WGCNA and single-cell sequence analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib6","doi-asserted-by":"crossref","first-page":"H141","DOI":"10.1152\/ajpheart.00100.2019","article-title":"Adaptive immune cells in calcific aortic valve disease","volume":"317","author":"Raddatz","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120640_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12933-024-02224-z","article-title":"Inhibition of Slc39a14\/Slc39a8 reduce vascular calcification via alleviating iron overload induced ferroptosis in vascular smooth muscle cells","volume":"23","author":"Aierken","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120640_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-021-04054-3","article-title":"Ferroptosis: the potential value target in atherosclerosis","volume":"12","author":"Ouyang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120640_bib10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.kint.2022.07.034","article-title":"Repression of the antiporter SLC7A11\/glutathione\/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification","volume":"102","author":"Ye","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120640_bib11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/ehf2.15132","article-title":"Increased calcification by erythrophagocytosis in aortic valvular interstitial cells","volume":"12","author":"Qin","year":"2025","journal-title":"ESC Heart Failur"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2022.03.013","article-title":"Iron promotes Slc7a11-deficient valvular interstitial cell osteogenic differentiation: a possible mechanism by which ferroptosis participates in intraleaflet hemorrhage-induced calcification","volume":"184","author":"Xu","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120640_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2015-05-644583","article-title":"CCL5 derived from platelets increases megakaryocyte proplatelet formation","volume":"127","author":"Machlus","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2024.104891","article-title":"The CCL5\/CCR5 axis in ulcerative colitis","volume":"407","author":"Qu","year":"2025","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12967-023-04044-3","article-title":"CCL5\/CCR5-mediated peripheral inflammation exacerbates blood\u2012brain barrier disruption after intracerebral hemorrhage in mice","volume":"21","author":"Lin","year":"2023","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120640_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.123.21888","article-title":"Role of the CCL5 and its receptor, CCR5, in the genesis of aldosterone-induced hypertension, vascular dysfunction, and end-organ damage","volume":"81","author":"Costa","year":"2024","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12883-023-03079-9","article-title":"Elevated RANTES levels are associated with increased risk of cerebral atherosclerotic stenosis","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.thromres.2016.06.013","article-title":"CCL5 deficiency reduces neointima formation following arterial injury and thrombosis in apolipoprotein E-deficient mice","volume":"144","author":"Czepluch","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145987","article-title":"Exploring potential genes and pathways related to calcific aortic valve disease","volume":"808","author":"Qiao","year":"2022","journal-title":"Gene"},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2026.120640_bib20","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120640_bib21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci : Publ Protein Soc"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib23","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1038\/s41467-022-33202-2","article-title":"Single-cell transcriptomics reveal cellular diversity of aortic valve and the immunomodulation by PPAR\u03b3 during hyperlipidemia","volume":"13","author":"Lee","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120640_bib24","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.7150\/thno.85323","article-title":"Platelet membrane-coated alterbrassicene A nanoparticle inhibits calcification of the aortic valve by suppressing phosphorylation P65 NF-\u03baB","volume":"13","author":"Geng","year":"2023","journal-title":"Theranostics"},{"issue":"52","key":"10.1016\/j.atherosclerosis.2026.120640_bib25","doi-asserted-by":"crossref","first-page":"E5088","DOI":"10.1073\/pnas.1312515110","article-title":"Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein","volume":"110","author":"Quoyer","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120640_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10090386","article-title":"Liraglutide attenuates aortic valve calcification in a high-cholesterol-diet-induced experimental calcific aortic valve disease model in apolipoprotein E-Deficient mice","volume":"10","author":"Zhou","year":"2023","journal-title":"J Cardiovasc Develop Dis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120640_bib27","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1080\/15548627.2021.1909833","article-title":"Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages","volume":"17","author":"Zhang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib28","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2147\/JIR.S415974","article-title":"High-dose vitamin C alleviates pancreatic necrosis by inhibiting platelet activation through the CXCL12\/CXCR4 pathway in severe acute pancreatitis","volume":"16","author":"Gui","year":"2023","journal-title":"J Inflamm Res"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120640_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","article-title":"Calcific aortic valve disease: mechanisms, prevention and treatment","volume":"20","author":"Moncla","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120640_bib30","article-title":"Morusin alleviates aortic valve calcification by inhibiting valve interstitial cell senescence through Ccnd1\/Trim25\/Nrf2 axis","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"30","key":"10.1016\/j.atherosclerosis.2026.120640_bib31","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1093\/eurheartj\/ehab316","article-title":"DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176423","article-title":"SIRT6-mediated Runx2 downregulation inhibits osteogenic differentiation of human aortic valve interstitial cells in calcific aortic valve disease","volume":"968","author":"Xiong","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155337","article-title":"Long noncoding TSI attenuates aortic valve calcification by suppressing TGF-\u03b21-induced osteoblastic differentiation of valve interstitial cells","volume":"138","author":"Liu","year":"2023","journal-title":"Metab Clin Exp"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120640_bib34","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1111\/bph.13705","article-title":"Perivascular adipose tissue inflammation in vascular disease","volume":"174","author":"Nosalski","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667690","article-title":"Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib36","article-title":"Potential ferroptosis key genes in calcific aortic valve disease","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115379","article-title":"Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPAR\u03b1","volume":"208","author":"Chen","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12933-025-02797-3","article-title":"SREBP1 deficiency aggravates vascular calcification via iASPP-triggered ferroptosis of vascular smooth muscle cells","volume":"24","author":"Wu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2024.06.004","article-title":"Nesfatin-1 mitigates calcific aortic valve disease via suppressing ferroptosis mediated by GSH\/GPX4 and ZIP8\/SOD2 axes","volume":"222","author":"Wang","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"Pt 2","key":"10.1016\/j.atherosclerosis.2026.120640_bib40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semcancer.2022.03.002","article-title":"Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers","volume":"86","author":"Arora","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120640_bib41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1055\/s-0038-1676988","article-title":"Atypical chemokine receptors in cardiovascular disease","volume":"119","author":"Gencer","year":"2019","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120640_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/15353702221118088","article-title":"Identification of key genes involved in calcific aortic valve disease based on integrated bioinformatics analysis","volume":"248","author":"Liu","year":"2023","journal-title":"Exp Biol Med (Maywood, NJ, U S)"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lfs.2019.04.050","article-title":"CC chemokine receptor 2 functions in osteoblastic transformation of valvular interstitial cells","volume":"228","author":"Zhu","year":"2019","journal-title":"Life Sci"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120640_bib44","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/cvr\/cvad117","article-title":"Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2","volume":"119","author":"Dhayni","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120640_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006339","article-title":"Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification","volume":"6","author":"Rutkovskiy","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2026.120640_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176357","article-title":"Advance in the role of chemokines\/chemokine receptors in carcinogenesis: focus on pancreatic cancer","volume":"967","author":"Song","year":"2024","journal-title":"Eur J Pharmacol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T19:37:02Z","timestamp":1785958622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"alternative-id":["S0021915026000067"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120640","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing CCL5 suppresses ferroptosis to alleviate calcific aortic valve disease through chemokine pathway inhibition","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120640"}}